James Hambro & Partners Sarepta Therapeutics, Inc. Transaction History
James Hambro & Partners
- $2.25 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
83.9MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.22 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.06 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$739 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$514 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$504 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.3B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...